1-236808698-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000254.3(MTR):​c.340-6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0291 in 1,613,758 control chromosomes in the GnomAD database, including 1,421 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 385 hom., cov: 32)
Exomes 𝑓: 0.026 ( 1036 hom. )

Consequence

MTR
NM_000254.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00002343
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.58

Publications

14 publications found
Variant links:
Genes affected
MTR (HGNC:7468): (5-methyltetrahydrofolate-homocysteine methyltransferase) This gene encodes the 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
MTR Gene-Disease associations (from GenCC):
  • methylcobalamin deficiency type cblG
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-236808698-C-T is Benign according to our data. Variant chr1-236808698-C-T is described in ClinVar as Benign. ClinVar VariationId is 138287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTRNM_000254.3 linkc.340-6C>T splice_region_variant, intron_variant Intron 3 of 32 ENST00000366577.10 NP_000245.2 Q99707-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTRENST00000366577.10 linkc.340-6C>T splice_region_variant, intron_variant Intron 3 of 32 1 NM_000254.3 ENSP00000355536.5 Q99707-1

Frequencies

GnomAD3 genomes
AF:
0.0549
AC:
8357
AN:
152160
Hom.:
383
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0404
Gnomad ASJ
AF:
0.00864
Gnomad EAS
AF:
0.0539
Gnomad SAS
AF:
0.0900
Gnomad FIN
AF:
0.0165
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0211
Gnomad OTH
AF:
0.0507
GnomAD2 exomes
AF:
0.0378
AC:
9494
AN:
251404
AF XY:
0.0377
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.0315
Gnomad ASJ exome
AF:
0.00913
Gnomad EAS exome
AF:
0.0521
Gnomad FIN exome
AF:
0.0169
Gnomad NFE exome
AF:
0.0206
Gnomad OTH exome
AF:
0.0342
GnomAD4 exome
AF:
0.0265
AC:
38658
AN:
1461480
Hom.:
1036
Cov.:
31
AF XY:
0.0279
AC XY:
20257
AN XY:
727068
show subpopulations
African (AFR)
AF:
0.132
AC:
4402
AN:
33446
American (AMR)
AF:
0.0330
AC:
1476
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
264
AN:
26134
East Asian (EAS)
AF:
0.0632
AC:
2509
AN:
39694
South Asian (SAS)
AF:
0.0770
AC:
6642
AN:
86238
European-Finnish (FIN)
AF:
0.0168
AC:
900
AN:
53416
Middle Eastern (MID)
AF:
0.0506
AC:
292
AN:
5768
European-Non Finnish (NFE)
AF:
0.0182
AC:
20239
AN:
1111692
Other (OTH)
AF:
0.0320
AC:
1934
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
1936
3871
5807
7742
9678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0550
AC:
8376
AN:
152278
Hom.:
385
Cov.:
32
AF XY:
0.0553
AC XY:
4121
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.127
AC:
5259
AN:
41532
American (AMR)
AF:
0.0402
AC:
615
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00864
AC:
30
AN:
3472
East Asian (EAS)
AF:
0.0540
AC:
280
AN:
5184
South Asian (SAS)
AF:
0.0896
AC:
433
AN:
4832
European-Finnish (FIN)
AF:
0.0165
AC:
175
AN:
10616
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0211
AC:
1437
AN:
68032
Other (OTH)
AF:
0.0506
AC:
107
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
406
812
1219
1625
2031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0321
Hom.:
289
Bravo
AF:
0.0591
Asia WGS
AF:
0.0810
AC:
284
AN:
3478
EpiCase
AF:
0.0236
EpiControl
AF:
0.0216

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 03, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Disorders of Intracellular Cobalamin Metabolism Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Methylcobalamin deficiency type cblG Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.1
DANN
Benign
0.54
PhyloP100
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=70/30
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000023
dbscSNV1_RF
Benign
0.074
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7526063; hg19: chr1-236971998; COSMIC: COSV63967404; API